PharmaGuy
PMN Home | Advertising Information | FAQs
About Us | Contact Us | Privacy Policy
Subscribe Glossary
Pharma Marketing Blog Pharmaguy Audio Podcasts Event Calendar PReader Surveys
Share |

Patients Speak For and Against Direct-to-Consumer Off-Label Promotion of Drugs
For or Against Off-Label DTCIn these audio snippets, several anonymous patients and patient advocates tell why they are in favor of or against allowing pharmaceutical companies to promote/advertise off-label uses of drugs directly to patients.

These patients were interviewed via the inVibe platform, which engages research participants (patients, physicians, and payors) on their smartphones and collects responses via automated, voice-response surveys. Learn more at www.invibe.co.

The survey was done in preparation for FDA's Part 15 public hearing on "Manufacturer Communications Regarding Unapproved Uses of Approved or Cleared Medical Products" on 9-10 November, 2016 (see below). Pharma Marketing News is also hosting a survey of readers on this topic (click here).

Comments in favor:
Comments against:

Links to More Information





Messages from Our Sponsors

Contact Information
Pharmaguy
Pharma Marketing Network

Pharma Marketing News | Subscribe | Industry Insights | Podcasts | Pharmaguy | Blog
Surveys | Glossary | Conference Calendar | Advertising Information | FAQs | About Us | Privacy Policy

© 2014. Pharma Marketing Network. All rights reserved.